Skip to main content
رجوع
Watch Compare

Kraig Biocraft Laboratories, Inc.

جودة البيانات: 83%
KBLB
OTC Manufacturing Chemicals
KWD 0.14
▲ KWD 0.01 (6.15%)
القيمة السوقية: 151.77 M
السعر
KWD 0.14
القيمة السوقية
151.77 M
نطاق اليوم
KWD 0.13 — KWD 0.14
نطاق 52 أسبوعًا
KWD 0.07 — KWD 0.15
حجم التداول
616,710
فتح KWD 0.13
متوسط 50 يوم / 200 يوم
KWD 0.11
26.61% above
متوسط 50 يوم / 200 يوم
KWD 0.09
51.65% above

Quick Summary

النقاط الرئيسية

Negative free cash flow of -1.79 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio0.16
Interest Coverage-5.91

التقييم

PE (TTM)
-41.89
أقل من متوسط القطاع (-1.98)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (44 نظير)
المقياس السهم وسيط القطاع
P/E -41.9 -2.0
P/B — 5.1
ROE % — -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -3.62 M
ROE N/A ROA -183.56%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -1.79 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.16
Interest Coverage -5.91 Asset Turnover N/A
Working Capital -8.54 M Tangible Book Value -7.96 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -41.89 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -1.18%
Market Cap 151.77 M Enterprise Value 150.21 M
Per Share
EPS (Diluted TTM) 0.00 Revenue / Share N/A
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 49.52%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -3.62 M -3.40 M -3.03 M -3.84 M -8.05 M
EPS (Diluted) 0.00 0.00 0.00 — —
Gross Profit — — — — —
Operating Income -3.37 M -3.07 M -2.61 M -2.12 M -2.76 M
EBITDA — — — — —
R&D Expenses 165,758.0 164,374.0 237,871.0 176,431.0 197,745.0
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 570,709.0 529,603.0 153,955.0 153,955.0 238,110.0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2.57 M 1.51 M 3.23 M 4.57 M 3.02 M
Total Liabilities 10.56 M 9.65 M 8.94 M 8.09 M 8.32 M
Shareholders' Equity -8.00 M -8.15 M -5.71 M -3.52 M -5.30 M
Total Debt — — — — —
Cash & Equivalents 1.79 M 673,264.0 2.55 M — —
Current Assets 1.87 M 740,285.0 2.57 M 3.98 M 2.37 M
Current Liabilities 10.45 M 9.61 M 8.89 M 8.07 M 8.16 M